New Therapeutics in Endometriosis: A Review of Hormonal, Non-Hormonal, and Non-Coding RNA Treatments

Int J Mol Sci. 2021 Sep 28;22(19):10498. doi: 10.3390/ijms221910498.

Abstract

Endometriosis is defined as endometrial-like tissue outside the uterine cavity. It is a chronic inflammatory estrogen-dependent disease causing pain and infertility in about 10% of women of reproductive age. Treatment nowadays consists of medical and surgical therapies. Medical treatments are based on painkillers and hormonal treatments. To date, none of the medical treatments have been able to cure the disease and symptoms recur as soon as the medication is stopped. The development of new biomedical targets, aiming at the cellular and molecular mechanisms responsible for endometriosis, is needed. This article summarizes the most recent medications under investigation in endometriosis treatment with an emphasis on non-coding RNAs that are emerging as key players in several human diseases, including cancer and endometriosis.

Keywords: angiogenesis; apoptosis; cell migration; cell proliferation; endometriosis; fibrosis; inflammation; non-coding RNA; stem cells.

Publication types

  • Review

MeSH terms

  • Animals
  • Drug Delivery Systems*
  • Endometriosis* / drug therapy
  • Endometriosis* / metabolism
  • Endometriosis* / pathology
  • Female
  • Humans
  • RNA, Untranslated / metabolism*

Substances

  • RNA, Untranslated